Bipolar disorder

Teva
Favicon Fierce Biotech

Teva saddles up as bidder for bankrupt BioXcel’s CNS assets

BioXcel Therapeutics has filed for bankruptcy and lined up a deal for Teva Pharmaceutical to acquire its assets for $57.5 million upfront.
Nick Paul Taylor Aug 28, 2026 9:17am
JNJ

J&J acquires CNS specialist Intra-Cellular for $14.6B

Jan 13, 2025 10:29am
depression major depressive disorder

Intra-Cellular closing in on major depression nod for Caplyta

Jun 18, 2024 11:40am
FDA

15 years later, Vanda secures another FDA nod for Fanapt

Apr 3, 2024 11:04am
Alkermes

Alkermes reports strong trajectory for Lybalvi, shares up 10%

Feb 15, 2024 1:10pm
A screenshot from Intra-Cellular Therapies Caplyta Dawn Poolout ad

Intra-Cellular re-ups winning ad as bipolar drug builds momentum

Aug 8, 2023 12:51pm